Evidence for selective benefit of sequential treatment with azanucleosides in patients with myelodysplastic syndromes (MDS).
Rami S. Komrokji
No relevant relationships to disclose
Susmitha Apuri
No relevant relationships to disclose
Najla Al Ali
No relevant relationships to disclose
Eric Padron
No relevant relationships to disclose
Javier Pinilla-Ibarz
No relevant relationships to disclose
Viet Ho
No relevant relationships to disclose
Alan F. List
No relevant relationships to disclose
Jeffrey E. Lancet
No relevant relationships to disclose